Shares of Arno Therapeutics, Inc. (OTCMKTS:ARNI – Get Free Report) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares trading hands.
Arno Therapeutics Stock Down 100.0%
Arno Therapeutics Company Profile
Arno Therapeutics, Inc, a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men.
Featured Stories
- Five stocks we like better than Arno Therapeutics
- Transportation Stocks Investing
- Meta’s 5 Key Pillars for AI Growth—Zuckerberg’s Bold Vision
- Technology Stocks Explained: Here’s What to Know About Tech
- Retail Investors Are Betting Big on Rocket Lab—Should You Too?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine
Receive News & Ratings for Arno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arno Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
